Vectocell Technology Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Vectocell Technology General Information
Description
An intracellular delivery technology. The technology is based on the fusion between the therapeutic protein and an antibody-derived peptide that facilitates passive entry into the cell thereby improving the performance of a therapeutic compound.
Contact Information
Corporate Office
- 166, boulevard du Montparnasse
- 75014 Paris
- France
Corporate Office
- 166, boulevard du Montparnasse
- 75014 Paris
- France
Vectocell Technology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vectocell Technology Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vectocell Technology FAQs
-
Where is Vectocell Technology headquartered?
Vectocell Technology is headquartered in Paris, France.
-
What industry is Vectocell Technology in?
Vectocell Technology’s primary industry is Buildings and Property.
-
Is Vectocell Technology a private or public company?
Vectocell Technology is a Private company.
-
What is Vectocell Technology’s current revenue?
The current revenue for Vectocell Technology is .
-
Who are Vectocell Technology’s investors?
Diatos has invested in Vectocell Technology.
-
When was Vectocell Technology acquired?
Vectocell Technology was acquired on 12-Oct-2009.
-
Who acquired Vectocell Technology?
Vectocell Technology was acquired by Cellectis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process